Profound Medical Corp. Common Stock (PROF) Stock Price

PROFStock

$6.81+44.07%52W

Market Cap$248.79M

P/E—

PEG Ratio—

Div yield—

Beta2.00

PROF Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-12.66%

Price vs S&P 500 (4W)-12.80%

VGM Score54.92

Book Value / Share (Quarterly)$1.64

P/TBV (Annual)3.24x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)34.06%

Cash Flow / Share (Quarterly)$-1.07

Price vs S&P 500 (YTD)-23.30%

Gross Margin (TTM)71.07%

Net Profit Margin (TTM)-206.76%

EPS (TTM)$-1.25

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-1.25

Revenue Growth (5Y)17.12%

EPS (Annual)$-1.41

ROI (Annual)-60.01%

Gross Margin (Annual)70.77%

Net Profit Margin (5Y Avg)-359.50%

Cash / Share (Quarterly)$1.38

Revenue Growth QoQ (YoY)103.62%

ROA (Last FY)-54.95%

Revenue Growth TTM (YoY)58.59%

EBITD / Share (TTM)$-1.19

ROE (5Y Avg)-58.99%

Operating Margin (TTM)-202.56%

Cash Flow / Share (Annual)$-1.06

P/B Ratio4.29x

P/B Ratio (Quarterly)3.90x

Net Income / Employee (Annual)$-325,000

EV / Revenue (TTM)11.11x

Net Interest Coverage (TTM)-38.77x

ROA (TTM)-64.06%

EPS Incl Extra (Annual)$-1.41

Current Ratio (Annual)12.52x

Quick Ratio (Quarterly)5.63x

3-Month Avg Trading Volume0.01M

52-Week Price Return44.07%

Revenue / Employee (TTM)$143,600

Tangible BV / Share (Quarterly)$1.63

P/S Ratio (Annual)15.82x

Asset Turnover (Annual)0.21x

52-Week High$12.40

Operating Margin (5Y Avg)-376.98%

EPS Excl Extra (Annual)$-1.41

CapEx CAGR (5Y)-7.11%

Tangible BV CAGR (5Y)-7.03%

26-Week Price Return-0.52%

Quick Ratio (Annual)11.02x

13-Week Price Return-0.32%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)6.56x

Enterprise Value$208.94M

Revenue / Share Growth (5Y)4.75%

Asset Turnover (TTM)0.31x

Book Value / Share Growth (5Y)-17.59%

Revenue / Employee (Annual)$122,900

Inventory Turnover (Annual)0.67x

Pretax Margin (Annual)-262.88%

Cash / Share (Annual)$1.65

3-Month Return Std Dev53.84%

Gross Margin (5Y Avg)57.14%

Net Income / Employee (TTM)$-296,900

ROE (Last FY)-64.08%

Net Interest Coverage (Annual)-8.13x

EPS Basic Excl Extra (Annual)$-1.41

Receivables Turnover (TTM)2.56x

Total Debt / Equity (Quarterly)0.08x

EPS Incl Extra (TTM)$-1.25

Receivables Turnover (Annual)2.36x

ROI (TTM)-72.30%

P/S Ratio (TTM)13.54x

Pretax Margin (5Y Avg)-358.38%

Revenue / Share (Annual)$0.53

Tangible BV / Share (Annual)$1.83

Price vs S&P 500 (52W)23.59%

Year-to-Date Return-11.98%

5-Day Price Return-2.87%

EPS Normalized (Annual)$-1.41

ROA (5Y Avg)-47.90%

Net Profit Margin (Annual)-264.44%

Month-to-Date Return-8.67%

Cash Flow / Share (TTM)$-1.82

EBITD / Share (Annual)$-1.35

Operating Margin (Annual)-256.27%

LT Debt / Equity (Annual)0.07x

ROI (5Y Avg)-52.16%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.25

P/TBV (Quarterly)3.91x

P/B Ratio (Annual)3.23x

Inventory Turnover (TTM)0.69x

Pretax Margin (TTM)-205.51%

Book Value / Share (Annual)$1.83

Price vs S&P 500 (13W)-3.62%

Beta2.00x

Revenue / Share (TTM)$0.52

ROE (TTM)-78.88%

52-Week Low$5.23

vGradeD

gGradeA

mGradeC

vgmGradeC

PROF Earnings Surprise History

Q2 25-0.52est. -0.40

Q3 25-0.26est. -0.38

Q4 25-0.27est. -0.27

Q1 26-0.19est. -0.25

Q2 26-0.26est. -0.24

PROF Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
PROFProfound Medical Corp. Common Stock	D	A	C	$6.81
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Profound Medical Corp. Common Stock

Profound Medical develops minimally invasive, image-guided ablation systems for treating prostate disease. Its flagship TULSA-PRO system combines real-time MRI guidance with robotic ultrasound technology to precisely ablate prostate tissue without surgical incisions. The system integrates with hospitals' existing MRI infrastructure, requiring only disposable devices and durable equipment.